Triple pill lowers risk of recurrent stroke by 39%
Researchers report that GMRx2, a single daily pill combining telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg, lowers the risk of recurrent stroke by 39%. The findings from the… read more.
Researchers report that GMRx2, a single daily pill combining telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg, lowers the risk of recurrent stroke by 39%. The findings from the… read more.
A study in Health Economics uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed… read more.
NICE(UK): Venetoclax plus obinutuzumab can be used, within its marketing authorisation, as an option for untreated chronic lymphocytic leukaemia (CLL) in adults. It can only be used if… read more.
People who have experienced childhood sexual abuse have twice the odds of receiving a cancer diagnosis at age 65 or older compared to others who have not experienced… read more.
A new study funded by the National Cancer Institute at the National Institutes of Health finds that how high school students perceive the costs of sun protection and the rewards of tanning… read more.
Advances in cancer treatment mean more people are living longer after a cancer diagnosis. But some survivors develop lymphedema—long-term swelling in the arms, hands, legs or feet that… read more.
“Healthy” food labels increased consumer selections of healthier snacks and consumers were willing to pay a premium for such labeled products, according to new research. In 2024, the… read more.
LENZ Therapeutics announced that it has submitted a Marketing Authorization Application (MAA) to the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for the review and approval… read more.
Researchers have already shown that mild to moderate exercise can reduce “chemo brain,” and a new study suggests that a low dose of an over-the-counter anti-inflammatory, ibuprofen, can… read more.
Organon announced that Vtama cream was granted a strong, evidence-based recommendation by the American Academy of Dermatology (AAD) in their 2026 guidelines for the management and treatment of… read more.
A routine component of many medical appointments—stepping on the scale to be weighed—may be a stigmatizing experience that raises patients’ blood pressure and potentially impacts their healthcare, according… read more.
Researchers at Toronto’s Sinai Health have found that semaglutide – the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1 – acts directly on a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.